Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marta Giovanetti is active.

Publication


Featured researches published by Marta Giovanetti.


Science | 2016

Zika virus in the Americas: Early epidemiological and genetic findings

Nuno Rodrigues Faria; Raimunda do Socorro da Silva Azevedo; Moritz U. G. Kraemer; Renato Souza; Mariana Sequetin Cunha; Sarah C. Hill; Julien Thézé; Michael B. Bonsall; Thomas A. Bowden; Ilona Rissanen; Iray Maria Rocco; Juliana Silva Nogueira; Adriana Yurika Maeda; Fernanda Giseli da Silva Vasami; Fernando Luiz de Lima Macedo; Akemi Suzuki; Sueli Guerreiro Rodrigues; Ana Cecília Ribeiro Cruz; Bruno Tardeli Nunes; Daniele Barbosa de Almeida Medeiros; Daniela Sueli Guerreiro Rodrigues; Alice Louize Nunes Queiroz; Eliana Vieira Pinto da Silva; Daniele Freitas Henriques; Elisabeth Salbe Travassos da Rosa; Consuelo Silva de Oliveira; Lívia Carício Martins; Helena Baldez Vasconcelos; L. M. N. Casseb; Darlene de Brito Simith

Zika virus genomes from Brazil The Zika virus outbreak is a major cause for concern in Brazil, where it has been linked with increased reports of otherwise rare birth defects and neuropathology. In a phylogenetic analysis, Faria et al. infer a single introduction of Zika to the Americas and estimated the introduction date to be about May to December 2013—some 12 months earlier than the virus was reported. This timing correlates with major events in the Brazilian cultural calendar associated with increased traveler numbers from areas where Zika virus has been circulating. A correlation was also observed between incidences of microcephaly and week 17 of pregnancy. Science, this issue p. 345 Virus sequencing indicates that Zika arrived in Brazil during the middle of 2013, coincident with a surge in air travelers. Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with ~30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.


Nature | 2017

Establishment and cryptic transmission of Zika virus in Brazil and the Americas

Nuno Rodrigues Faria; Josh Quick; Julien Thézé; J. G. de Jesus; Marta Giovanetti; Moritz U. G. Kraemer; Sarah C. Hill; Allison Black; A. C. da Costa; Luciano Franco; Sandro Patroca da Silva; Chieh-Hsi Wu; Jayna Raghwani; Simon Cauchemez; L. du Plessis; M. P. Verotti; W. K. de Oliveira; E. H. Carmo; Giovanini Evelim Coelho; A. C. F. S. Santelli; L. C. Vinhal; C. M. Henriques; Jared T. Simpson; Matthew Loose; Kristian G. Andersen; Nathan D. Grubaugh; Sneha Somasekar; Charles Y. Chiu; José Esteban Muñoz-Medina; César González-Bonilla

Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil. Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 2016) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 2016). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease. However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.


Journal of Experimental & Clinical Cancer Research | 2015

Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi’s sarcoma and non-Kaposi’s cases

Paola Cordiali-Fei; Elisabetta Trento; Marta Giovanetti; Alessandra Lo Presti; Alessandra Latini; Massimo Giuliani; Giovanna D’Agosto; Valentina Bordignon; Eleonora Cella; Francesca Farchi; Carmela Ferraro; Ilaria Lesnoni La Parola; Carlo Cota; Isabella Sperduti; Antonella Vento; Antonio Cristaudo; Massimo Ciccozzi; Fabrizio Ensoli

BackgroundClassical Kaposi’s Sarcoma (cKS) is a rare vascular tumor, which develops in subjects infected with Human Herpesvirus-8 (HHV-8). Beside the host predisposing factors, viral genetic variants might possibly be related to disease development. The aim of this study was to identify HHV-8 variants in patients with cKS or in HHV-8 infected subjects either asymptomatic or with cKS-unrelated cutaneous lymphoproliferative disorders.MethodsThe VR1 and VR2 regions of the ORF K1 sequence were analyzed in samples (peripheral blood and/or lesional tissue) collected between 2000 and 2010 from 27 subjects with HHV-8 infection, established by the presence of anti-HHV-8 antibodies. On the basis of viral genotyping, a phylogenetic analysis and a time-scaled evaluation were performed.ResultsTwo main clades of HHV-8, corresponding to A and C subtypes, were identified. Moreover, for each subtype, two main clusters were found distinctively associated to cKS or non-cKS subjects. Selective pressure analysis showed twelve sites of the K1 coding gene (VR1 and VR2 regions) under positive selective pressure and one site under negative pressure.ConclusionThus, present data suggest that HHV-8 genetic variants may influence the susceptibility to cKS in individuals with HHV-8 infection.


Nature Protocols | 2017

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Joshua Quick; Nathan D. Grubaugh; Steven T. Pullan; Ingra M Claro; Andrew D Smith; Karthik Gangavarapu; Glenn Oliveira; Refugio Robles-Sikisaka; Thomas F. Rogers; Nathan Beutler; Dennis R. Burton; Lia Laura Lewis-Ximenez; Jaqueline Goes Jesus; Marta Giovanetti; Sarah C. Hill; Allison Black; Trevor Bedford; Miles W. Carroll; Márcio Roberto Teixeira Nunes; Luiz Carlos Junior Alcantara; Ester C. Sabino; Sally A. Baylis; Nuno Rodrigues Faria; Matthew Loose; Jared T. Simpson; Oliver G. Pybus; Kristian G. Andersen; Nicholas J. Loman

Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences can be achieved in 1–2 d by starting with clinical samples and following a simple laboratory workflow. This method has been successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method for use in the lab.


Infection, Genetics and Evolution | 2013

Epidemiological history and phylogeography of West Nile virus lineage 2

Massimo Ciccozzi; Simone Peletto; Eleonora Cella; Marta Giovanetti; Alessia Lai; Elena Gabanelli; Pier Luigi Acutis; Paola Modesto; Giovanni Rezza; Alexander E. Platonov; Alessandra Lo Presti; Gianguglielmo Zehender

West Nile virus (WNV) was first isolated in Uganda. In Europe WNV was sporadically detected until 1996, since then the virus has been regularly isolated from birds and mosquitoes and caused several outbreaks in horses and humans. Phylogenetic analysis showed two main different WNV lineages. The lineage 1 is widespread and segregates into different subclades (1a-c). WNV-1a includes numerous strains from Africa, America, and Eurasia. The spatio-temporal history of WNV-1a in Europe was recently described, identifying two main routes of dispersion, one in Eastern and the second in Western Europe. The West Nile lineage 2 (WNV-2) is mainly present in sub-Saharan Africa but has been recently emerged in Eastern and Western European countries. In this study we reconstruct the phylogeny of WNV-2 on a spatio-temporal scale in order to estimate the time of origin and patterns of geographical dispersal of the different isolates, particularly in Europe. Phylogeography findings obtained from E and NS5 gene analyses suggest that there were at least two separate introductions of WNV-2 from the African continent dated back approximately to the year 1999 (Central Europe) and 2000 (Russia), respectively. The epidemiological implications and clinical consequences of lineage 1 and 2 cocirculation deserve further investigations.


Scientific Reports | 2015

Impact of spatial dispersion, evolution, and selection on Ebola Zaire Virus epidemic waves

Taj Azarian; Alessandra Lo Presti; Marta Giovanetti; Eleonora Cella; Brittany D. Rife; Alessia Lai; Gianguglielmo Zehender; Massimo Ciccozzi; Marco Salemi

Ebola virus Zaire (EBOV) has reemerged in Africa, emphasizing the global importance of this pathogen. Amidst the response to the current epidemic, several gaps in our knowledge of EBOV evolution are evident. Specifically, uncertainty has been raised regarding the potential emergence of more virulent viral variants through amino acid substitutions. Glycoprotein (GP), an essential component of the EBOV genome, is highly variable and a potential site for the occurrence of advantageous mutations. For this study, we reconstructed the evolutionary history of EBOV by analyzing 65 GP sequences from humans and great apes over diverse locations across epidemic waves between 1976 and 2014. We show that, although patterns of spatial dispersion throughout Africa varied, the evolution of the virus has largely been characterized by neutral genetic drift. Therefore, the radical emergence of more transmissible variants is unlikely, a positive finding, which is increasingly important on the verge of vaccine deployment.


Open Forum Infectious Diseases | 2015

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors

Andrea De Luca; Simona Di Giambenedetto; Alessandra Lo Presti; Saleta Sierra; Mattia Prosperi; Eleonora Cella; Marta Giovanetti; Carlo Torti; Cinzia Caudai; Ilaria Vicenti; Francesco Saladini; Paolo Almi; Pierfrancesco Grima; Pierluigi Blanc; Massimiliano Fabbiani; Barbara Rossetti; Roberta Gagliardini; Rolf Kaiser; Massimo Ciccozzi; Maurizio Zazzi

Background. Hepatitis C virus (HCV) genotype 1 is the most prevalent worldwide. Subtype 1a, compared with 1b, shows lower response rates and higher propensity to select for drug resistance to NS3 and selected NS5A and nonnucleoside NS5B inhibitors. Two distinct clades of subtype 1a have been described. Methods. Using Bayesian methodology, we performed a time-scaled phylogeny reconstruction of clade separation and characterized the geographic distribution, phylodynamics, and association with natural resistance variants of NS3 sequences from 362 patients carrying subtype 1a HCV. Results. All sequences segregated in 2 clearly distinct clades. Clade I showed an earlier origin from the common ancestor compared with clade II. Clade I virus was more prevalent in non-European countries, represented mostly by United States, compared with European (75.7% vs 49.3%; P < .001). The prevalence of the natural NS3 variant Q80K, associated with resistance to the macrocyclic protease inhibitor simeprevir, was detected in 51.6% of clade I and 0% of clade II (P < .001); clade I showed a lower genetic barrier for Q80K, whereas no sign of selective pressure at any protease inhibitor resistance-associated codon was detected. Conclusions. Hepatitis C virus subtype 1a clades have a clearly different distribution in Europe and the United States, and the natural resistance mutation Q80K is exclusively associated with clade I.


Infection, Genetics and Evolution | 2016

Zika virus complete genome from Salvador, Bahia, Brazil.

Marta Giovanetti; Nuno Rodrigues Faria; Márcio Roberto Teixeira Nunes; Janaina Mota de Vasconcelos; José Lourenço; Sueli Guerreiro Rodrigues; João Vianez; Sandro Patroca da Silva; Poliana da Silva Lemos; Fernando Neto Tavares; Darren P. Martin; Mateus Santana do Rosário; Isadora Siqueira; Massimo Ciccozzi; Oliver G. Pybus; Tulio de Oliveira; Luiz Carlos Junior Alcantara

In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak.


Journal of Clinical Microbiology | 2013

Full-Genome Characterization of a G8P[8] Rotavirus That Emerged among Children with Diarrhea in Croatia in 2006

Roberto Delogu; Alessandra Lo Presti; Franco Maria Ruggeri; Eleonora Cella; Marta Giovanetti; Massimo Ciccozzi; Sunčanica Ljubin-Sternak; Suzana Bukovski-Simonoski; Amarela Lukić-Grlić; Giovanni Ianiro; Lucia Fiore

ABSTRACT The whole genome of a G8P[8] rotavirus from the 2006 epidemic in Croatia was sequenced and showed a Wa-like genotype constellation. Its VP7 gene clustered with DS-1-like G8 African rotaviruses and a G8P[4] German strain. Remaining genes clustered with contemporary Belgian G1P[8] rotaviruses, suggesting reassortment between human G8 and G1P[8] rotaviruses in Croatia or other European countries.


Hepatitis Monthly | 2016

HEPATITIS E VIRUS CIRCULATION IN ITALY: PHYLOGENETIC AND EVOLUTIONARY ANALYSIS

Carla Montesano; Marta Giovanetti; Marco Ciotti; Eleonora Cella; Alessandra Lo Presti; Alba Grifoni; Gianguglielmo Zehender; Silvia Angeletti; Massimo Ciccozzi

Background Hepatitis E virus (HEV), a major cause of acute viral hepatitis in developing countries, has been classified into four main genotypes and a number of subtypes. New genotypes have been recently identified in various mammals, including HEV genotype 3, which has a worldwide distribution. It is widespread among pigs in developed countries. Objectives This study investigated the genetic diversity of HEV among humans and swine in Italy. The date of origin and the demographic history of the HEV were also estimated. Materials and Methods A total of 327 HEV sequences of swine and humans from Italy were downloaded from the national centre for biotechnology information. Three different data sets were constructed. The first and the second data set were used to confirm the genotype of the sequences analyzed. The third data set was used to estimate the mean evolutionary rate and to determine the time-scaled phylogeny and demographic history. Results The Bayesian maximum clade credibility tree and the time of the most common recent ancestor estimates showed that the root of the tree dated back to the year 1907 (95% HPD: 1811 - 1975). Two main clades were found, divided into two subclades. Skyline plot analysis, performed separately for human and swine sequences, demonstrated the presence of a bottleneck only in the skyline plot from the swine sequences. Selective pressure analysis revealed only negatively selected sites. Conclusions This study provides support for the hypothesis that humans are probably infected after contact with swine sources. The findings emphasize the importance of checking the country of origin of swine and of improving sanitary control measures from the veterinary standpoint to prevent the spread of HEV infection in Italy.

Collaboration


Dive into the Marta Giovanetti's collaboration.

Top Co-Authors

Avatar

Massimo Ciccozzi

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Eleonora Cella

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Alessandra Lo Presti

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Silvia Angeletti

Università Campus Bio-Medico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marco Ciotti

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

Alba Grifoni

University of Rome Tor Vergata

View shared research outputs
Researchain Logo
Decentralizing Knowledge